- 1. 776C85/5-FU
- [A combination tablet of ethynyluracil and fluorouracil. Fluorouracil is an antimetabolite fluoropyrimidine analog of the nucleoside pyrimidine with antineoplastic activity. Ethynyluracil is an orally-active fluoropyrimidine analog that inhibits dihydropyrimidine dehydrogenase, the rate-limiting enzyme that catabolizes and inactivates 5-fluorouracil in the liver. This may lead to an increase in the bioavailability and, effectiveness of fluorouracil. ( NCI )] (UMLS (NCI) C0393027) =Therapeutic or Preventive Procedure
| - 41. CF/5-FU/TSPA
- (UMLS (NCI) C0280735) =Therapeutic or Preventive Procedure ;
|
- 2. C fiber
- [unmyelinated sensory axons in peripheral nerves which carry slow pain responses; attached nociceptors are thought to be activated by a chemical released into the extracellular fluid as a result of tissue damage; widely distributed in deep tissue as well as skin. ( CSP )] (UMLS (CSP) C0006549) =Body Part, Organ, or Organ Component ;
=somatic afferent nerve; | - 42. CF/5-FU/VP-16
- (UMLS (NCI) C0280966) =Therapeutic or Preventive Procedure ;
|
- 3. c fms
- [ ] (UMLS (CSP) C0079053) =Gene or Genome
| - 43. CF/5-FU/ZDV
- (UMLS (NCI) C0280902) =Therapeutic or Preventive Procedure
|
- 4. c fos
- [c-FOS protein is a transcription factor critical in regulating the development of the skeleton. c-FOS protein is a major component of the DNA-binding AP-1 transcription complex, which also includes members of the JUN family. Each protein contains a bZIP domain and a leucine zipper domain. FOS oncoproteins derive from mutated FOS genes. These proteins have been found in the Finkel-Biskis-Jinkins (FBJ-MSV) and Finkel-Biskis-Reilly (FBR-MSV) murine sarcoma viruses, which induce osteogenic sarcomas in mice. The FBJ-MSV v-fos gene encodes a 55 kD protein and the FBR-MSV v-fos gene encodes a 75 kD fusion protein. (from OMIM 164810 and NCI) ( NCI )] (UMLS (CSP) C0085301) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
◊ [ ] (UMLS (CSP) C0085940) Gene or Genome ; | - 44. CF/CTX/DHAD/5-FU
- (UMLS (NCI) C0279436) =Therapeutic or Preventive Procedure
|
- 5. c fps
- [ ] (UMLS (CSP) C0599897) =Gene or Genome ;
| - 45. CF/CTX/DOX/5-FU
- (UMLS (NCI) C0280447) =Therapeutic or Preventive Procedure
|
- 6. C-FER
- [FER (FPS/FES related) protein is a tyrosine kinase expressed in lymphoid cells; phosphoprotein NCP94. Inhibition of CDH2 (the cytoplasmic domain) or of beta-1 integrin function results in release of FER from the cadherin complex and accumulation in the integrin complex, suggesting that FER may shuttle between cadherin and integrin complexes, perhaps mediating cross-talk between CDH2 and ITGB1. (from OMIM 176942 and NCI) ( NCI )] (UMLS (NCI) C0072450) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 46. CF/CTX/DOX/5-FU/G-CSF
- (UMLS (NCI) C0281515) =Therapeutic or Preventive Procedure
|
- 7. c-FGR Protein
- [p55-FGR tyrosine kinase contains an SH2 domain, an SH3 domain and belongs to the SRC subfamily. (from OMIM 164940, Swiss-Prot P09769, and NCI) ( NCI )] (UMLS (NCI) C0072451) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 47. CF/CTX/DOX/5-FU/GM-CSF
- (UMLS (NCI) C0280454) =Therapeutic or Preventive Procedure
|
- 8. c-fos Protein
- [nuclear, DNA binding protein; regulates transcription; product of the c-fos proto-oncogene. ( CSP )] (UMLS (NCI) C0596588) =Amino Acid, Peptide, or Protein; Biologically Active Substance =DNA binding protein;
| - 48. CF/CTX/DOX/5-FU/GM-CSF/IL-3
- (UMLS (NCI) C0280980) =Therapeutic or Preventive Procedure
|
- 9. CF
- [A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon. (NCI) ( NCI )] (UMLS (NCI) C0009738) =Geographic Area ;
| - 49. CF/CTX/DOX/5-FU/IL-3
- (UMLS (NCI) C0280979) =Therapeutic or Preventive Procedure
|
- 10. CF Regimen
- [A regimen consisting of cisplatin and continuous ( NCI )] (UMLS (NCI) C0381056) =Therapeutic or Preventive Procedure
| - 50. CF/CTX/DOX/5-FU/PIXY321
- (UMLS (NCI) C0281455) =Therapeutic or Preventive Procedure ;
|
- 11. CF/5-FU/FUDR
- (UMLS (NCI) C0280110) =Therapeutic or Preventive Procedure
| - 51. CF/dFdC/FUDR
- (UMLS (NCI) C0338253) =Therapeutic or Preventive Procedure
|
- 12. CF/5-FU/FUDR/IFN-A
- (UMLS (NCI) C0338138) =Therapeutic or Preventive Procedure
| - 52. CF/DHAD/5-FU
- (UMLS (NCI) C0251760) =Therapeutic or Preventive Procedure
|
- 13. CF/5-FU/FUDR/LEV
- (UMLS (NCI) C0280844) =Therapeutic or Preventive Procedure
| - 53. CF/DHAD/5-FU/IFN-A/VBL
- (UMLS (NCI) C0338157) =Therapeutic or Preventive Procedure
|
- 14. CF/5-FU/G-CSF
- (UMLS (NCI) C0280921) =Therapeutic or Preventive Procedure
| - 54. CF/DHAD/5-FU/VCR
- (UMLS (NCI) C0280881) =Therapeutic or Preventive Procedure
|
- 15. CF/5-FU/G-CSF/TAX
- (UMLS (NCI) C0281449) =Therapeutic or Preventive Procedure
| - 55. CF/DM/FUDR
- (UMLS (NCI) C0281277) =Therapeutic or Preventive Procedure
|
- 16. CF/5-FU/GM-CSF
- (UMLS (NCI) C0279403) =Therapeutic or Preventive Procedure
| - 56. CF/DM/MP/MTX/VCR
- (UMLS (NCI) C0796449) Dexamethasone/Leucovorin Calcium/Mercaptopurine/Methotrexate/Vincristine;
=Therapeutic or Preventive Procedure |
- 17. CF/5-FU/HU
- (UMLS (NCI) C0279198) =Therapeutic or Preventive Procedure
| - 57. CF/DOX/5-FU
- (UMLS (NCI) C0295180) =Therapeutic or Preventive Procedure
|
- 18. CF/5-FU/ICI D1694/IFN-A
- (UMLS (NCI) C0338191) =Therapeutic or Preventive Procedure ;
| - 58. CF/DOX/5-FU/MITO
- (UMLS (NCI) C0280194) =Therapeutic or Preventive Procedure
|
- 19. CF/5-FU/IFN-A
- (UMLS (NCI) C0338127) =Therapeutic or Preventive Procedure ;
| - 59. CF/DOX/5-FU/VNB
- (UMLS (NCI) C0281300) =Therapeutic or Preventive Procedure
|
- 20. CF/5-FU/IFN-A/GM-CSF
- (UMLS (NCI) C0338181) =Therapeutic or Preventive Procedure
| - 60. CF/DP/5-FU
- (UMLS (NCI) C0279236) =Therapeutic or Preventive Procedure ;
|
- 21. CF/5-FU/IFN-A/IFN-G
- (UMLS (NCI) C0338165) =Therapeutic or Preventive Procedure
| - 61. CF/DP/5-FU/MITO
- (UMLS (NCI) C0281421) =Therapeutic or Preventive Procedure
|
- 22. CF/5-FU/IFN-A/MITO
- (UMLS (NCI) C0338160) =Therapeutic or Preventive Procedure
| - 62. CF/DP/5-FU/ZDV
- (UMLS (NCI) C0280766) =Therapeutic or Preventive Procedure
|
- 23. CF/5-FU/IFN-A/MTX
- (UMLS (NCI) C0338144) =Therapeutic or Preventive Procedure
| - 63. CF/EDAM
- (UMLS (NCI) C0281450) =Therapeutic or Preventive Procedure
|
- 24. CF/5-FU/IFN-A/VP-16
- (UMLS (NCI) C0338193) =Therapeutic or Preventive Procedure ;
| - 64. CF/FUDR
- (UMLS (NCI) C0279437) =Therapeutic or Preventive Procedure
|
- 25. CF/5-FU/IL-2
- (UMLS (NCI) C0279228) =Therapeutic or Preventive Procedure ;
| - 65. CF/FUDR/HU
- (UMLS (NCI) C0281510) =Therapeutic or Preventive Procedure
|
- 26. CF/5-FU/IL-2/LAK
- (UMLS (NCI) C0280883) =Therapeutic or Preventive Procedure
| - 66. CF/FUDR/L-PAM
- (UMLS (NCI) C0677743) =Therapeutic or Preventive Procedure ;
|
- 27. CF/5-FU/IUDR
- (UMLS (NCI) C0280862) =Therapeutic or Preventive Procedure ;
| - 67. CF/FUDR/PALA
- (UMLS (NCI) C0281384) =Therapeutic or Preventive Procedure ;
|
- 28. CF/5-FU/IUDR/PALA
- (UMLS (NCI) C0281024) =Therapeutic or Preventive Procedure
| - 68. CF/IUDR
- (UMLS (NCI) C0280913) =Therapeutic or Preventive Procedure
|
- 29. CF/5-FU/L-OHP
- (UMLS (NCI) C0392943) =Therapeutic or Preventive Procedure
| - 69. CF/MP/MTX
- (UMLS (NCI) C0281272) =Therapeutic or Preventive Procedure
|
- 30. CF/5-FU/MeCCNU
- (UMLS (NCI) C0279294) =Therapeutic or Preventive Procedure ;
| - 70. CF/MTX/VCR
- (UMLS (NCI) C0678007) =Therapeutic or Preventive Procedure
|
- 31. CF/5-FU/MITO
- (UMLS (NCI) C0281274) =Therapeutic or Preventive Procedure
| - 71. CF/TMTX
- (UMLS (NCI) C0281765) =Therapeutic or Preventive Procedure ;
|
- 32. CF/5-FU/MMPR/PALA
- (UMLS (NCI) C0281205) =Therapeutic or Preventive Procedure
| - 72. CF/UFT
- (UMLS (NCI) C0281746) =Therapeutic or Preventive Procedure
|
- 33. CF/5-FU/MOAB 17-1A
- (UMLS (NCI) C0392974) =Therapeutic or Preventive Procedure ;
| - 73. CFC1
- [This protein is a member of the epidermal growth factor (EGF)- Cripto, Frl-1, and Cryptic (CFC) family. EGF-CFC family member proteins share a variant EGF-like motif, a conserved cysteine-rich domain, and a C-terminal hydrophobic region. These proteins play key roles in intercellular signaling pathways during vertebrate embryogenesis. Mutations in this gene can cause autosomal visceral heterotaxy. This protein is involved in left-right asymmetric morphogenesis during organ development. (LocusLink) ( NCI )] (UMLS (NCI) C0535936) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 34. CF/5-FU/MTX
- (UMLS (NCI) C0066495) =Therapeutic or Preventive Procedure ;
| - 74. CFC1
- [This gene is involved in intercellular signaling during vertebrate embryogenesis. ( NCI )] (UMLS (NCI) C1332788) CFC1 Gene;
Cripto, FRL-1, Cryptic Family 1 Gene =Gene or Genome |
- 35. CF/5-FU/MTX/PALA/TAU
- (UMLS (NCI) C0281447) =Therapeutic or Preventive Procedure
| - 75. CFP
- (UMLS (NCI) C0055162) =Therapeutic or Preventive Procedure
|
- 36. CF/5-FU/PALA
- (UMLS (NCI) C0280692) =Therapeutic or Preventive Procedure
| - 76. CFPMV
- (UMLS (NCI) C0055987) =Therapeutic or Preventive Procedure
|
- 37. CF/5-FU/PALA/ZDV
- (UMLS (NCI) C0281025) =Therapeutic or Preventive Procedure
| - 77. CFS
- [distinctive syndrome characterized by chronic fatigue, mild fever, lymphadenopathy, headache, myalgia, arthralgia, depression, and memory loss; candidate etiologic agents include Epstein-Barr and other herpesviruses. ( CSP )] (UMLS (CSP) C0015674) =Disease or Syndrome =encephalomyelitis;
muscle disorder; syndrome; |
- 38. CF/5-FU/TAX
- (UMLS (NCI) C0281448) =Therapeutic or Preventive Procedure
| - 78. CFTR
- [A chloride channel that regulates secretion in many exocrine tissues. Abnormalities in the CFTR gene have been shown to cause cystic fibrosis. (Hum Genet 1994;93(4):364-8) ( MSH )] (UMLS (CSP) C0056889) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 39. CF/5-FU/TMTX
- (UMLS (NCI) C0281030) =Therapeutic or Preventive Procedure
| - 79. CFU-GM Assay
- [A functional (qualitative) as well as quantitative assay that is utilized as an indicator of granulopoiesis reconstitution. ( NCI )] (UMLS (NCI) C0201610) =Laboratory Procedure
|
- 40. CF/5-FU/TOPO
- (UMLS (NCI) C0338285) =Therapeutic or Preventive Procedure ;
| - 80. CFV
- [causes malignant reticulopathy in mice. ( CSP )] (UMLS (NCI) C0016720) =Virus ;
=MLV; |